INDIA MARKET LENS

Sun Pharmaceutical Industries Limited (SUNPHARMA): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Sun Pharmaceutical Industries Limited, explained in plain English.

  • Sun Pharmaceutical Industries Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
  • SUNPHARMA closed at ₹1,884.90 on 20 November 2026.
  • Over the past year the shares are up 5.9%, trading between ₹1,583.70 and ₹2,046.90.
  • Reported fundamentals show return on equity of 13.1%, a net margin of 17.79%, debt to equity of 3.62.
  • Our Pulse grade checklist scores it C (58/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
  • Annualised volatility over the past year is 19.73% with a maximum drawdown of -13.23% and a beta of 0.44 against NIFTY 50.
  • Recent coverage: Why Sun Pharma Advanced Research shares surge 11% despite weak sentiments on D-Street; what's boosting medical stock?
  • Recent coverage: Muhurat Trading 2026: Tata Steel, Sun Pharma, BSE among top gainers as Nifty 50, Sensex swing between gains and losses
  • Recent coverage: Muhurat Trading 2026 Diwali Session Opening Bell: How Sensex, Nifty is performing on special day; check gainers, losers

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 20 Nov 2026. Closed — weekend.

Sun Pharmaceutical Industries Limited (SUNPHARMA)

₹1,884.9

▼ 15.1 (-0.79%)

Price & volume

SUNPHARMA price chart, 1Y range. 252 points from 2025-11-25 to 2026-11-20. Opens at 1,776.8, closes at 1,884.9, ranging between 1,589.3 and 2,001.1.1,6001,7001,8001,9002,000Nov-25Jan-26Mar-26May-26Jun-26Aug-26Sep-26Nov-26volume

Hover for exact price & volume · green/red volume bars show up vs down days

Strong momentum · 4/5
✓ Above 50-day avg✓ Above 200-day avgRSI 61.6 · healthyMACD positiveBollinger %B 71ADX 31.5 · strong trend

1M

+8.14%

3M

-1.00%

6M

+0.24%

1Y

+6.05%

Where it sits in its 52-week range

72%
₹1,589.3₹2,001.1

Below 52-week high

5.8%

18.6% above the low

Momentum read

Strong

4/5 checks passed

52-wk high

₹2,001.1

52-wk low

₹1,589.3

Market cap

₹4,52,251 Cr

P/E (trailing)

41.2

Dividend yield

—

ROE

13.1%

Profit margin

17.79%

Revenue growth

11.9%

Price / Book

5.06

Debt / Equity

3.62

EPS (TTM)

45.7

Book value

₹372.65

Beta

0.44

Pulse grade: C, 58 out of 100

Momentum

B
  • ✓Trading above 50-day average
  • ✓Trading above 200-day average
  • ✓RSI in healthy 45-70 zone
  • ✕Positive 3-month return

Growth

F
  • ✕Revenue growth above Pharma & Healthcare median (20.8%)
  • ✓Revenue growing above 5%
  • ✕Quarterly profits trending up

Profitability

C
  • ✕Return on equity above Pharma & Healthcare median (14.56%)
  • ✓Return on equity above 12%
  • ✓Profit margin above Pharma & Healthcare median (13.82%)

Safety

A
  • ✓Debt below Pharma & Healthcare median (18.57)
  • ✓Debt not extreme for the sector
  • ✓Less volatile than the market (beta < 1.2)
  • ✕Pays a dividend

Quarterly revenue vs net profit

Revenue Net profit₹ crore, by quarter

Sep 2026: revenue ₹16,100 crore · net profit ₹1,989 crore · margin 12.4%

16,1000Jun 2025n/aSep 2025Dec 2025Mar 2026Jun 2026Sep 2026

Business quality

Intrinsic value

Building the model…

Analyst coverage

Who owns this company

Events, dividends & splits

Market position

Pharma & Healthcare sector

PeerPrice ₹Day changeFrom 52-wk high
DRREDDY1,390.2-0.76%-0.76%
CIPLA1,415-0.25%-7.59%
DIVISLAB11,180.5+0.02%-3.33%
APOLLOHOSP9,200+5.29%0.00%
LUPIN2,014+0.76%-19.91%
AUROPHARMA1,799-0.37%-3.03%

SUNPHARMA headlines

No SUNPHARMA stories right now.

SUNPHARMA filings & announcements

Reading the exchange…

SUNPHARMA, historical timeline

The timeline will be ready shortly

The rest of the page is unaffected.

Risk & return, last 12 months

Volatility (ann.)

19.73%

Sharpe ratio

0.08

Sortino ratio

0.12

Max drawdown

-13.23%

Daily VaR (95%)

-1.89%

CAGR (1Y)

6.11%

Return skew

0.65

Sharpe/Sortino use a 7% risk-free rate. VaR-95 = the daily loss exceeded only 5% of days last year.

Risk profile over time

Quant tearsheet

Monthly returns, how deep the falls ran, and how tightly it tracks NIFTY.

Analysis and research on Sun Pharmaceutical Industries